Prevention

DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore

Posted on Tuesday, June 19th, 2018 at 11:36 am.

DOTS Bulletin. June 2018. Issue 2.

Naloxone Recall—Two Lots From Hospira Recalled Due to Particulate Matter

Posted on Thursday, June 7th, 2018 at 11:21 am.

Recall from the FDA Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, […]